Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit

23 Jun 2020

Abstract excerpt

// Hee-Don Chae 1 , Ritika Dutta 1 , Bruce Tiu 1 , Fieke W. Hoff 2 , Benedetta Accordi 3 , Valentina Serafin 3 , Minyoung Youn 1 , Min Huang 1 , Nathan Sumarsono 1 , Kara L. Davis 1 , Norman J. Lacayo 1 , Martina Pigazzi 3 , Terzah M. Horton 4 , Steven M. Kornblau 5 and Kathleen M. Sakamoto 1 1 Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA 2 Department of Pediatric...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cell death mechanisms and regulation
Share to Microtubule and mitosis dynamics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32637030
DOI: 10.18632/oncotarget.27630

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exitPMID 32637030Read ↗

RSK Inhibition Induces Apoptosis by Downregulating Protein Synthesis in a Variety of Acute Myeloid Leukemia Cell Lines.Semantic proximity Read ↗

Upregulated mitosis-associated genes CENPE, CENPF, and DLGAP5 predict poor prognosis and chemotherapy resistance of Acute Myeloid LeukemiaSemantic proximity Read ↗

The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?Semantic proximity Read ↗

Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines.Semantic proximity Read ↗

The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemiaSemantic proximity Read ↗

Targeting cell cycle regulators in hematologic malignanciesSemantic proximity Read ↗

CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated CytotoxicitySemantic proximity Read ↗

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor GeneSemantic proximity Read ↗

Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.Semantic proximity Read ↗

ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathwaySemantic proximity Read ↗

Identification of the First Specific Inhibitor of p90 Ribosomal S6 Kinase (RSK) Reveals an Unexpected Role for RSK in Cancer Cell ProliferationSemantic proximity Read ↗

Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.